Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospital
Background Sacubitril/valsartan has been incorporated into guidelines based on the results of the PARADIGM-HF trial, which demonstrated reduced mortality in stable patients with heart failure with reduced ejection fraction (HFrEF). Sacubitril/valsartan is recommended in addition to other HF therapie...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Greater Baltimore Medical Center,
2020-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|